logo
  

Myriad Genetics Reports Regulatory Approval Of BRACAnalysis In Japan

Myriad Genetics, Inc. (MYGN) announced the Japan's Ministry of Health, Labour and Welfare has approved the BRACAnalysis Diagnostic System for Hereditary Breast and Ovarian Cancer risk assessment in patients with breast cancer.

BRACAnalysis is a genetic test that identifies germline mutations in the BRCA1/2 genes. This test will assist physicians in determining which women with breast cancer have Hereditary Breast and Ovarian Cancer syndrome and qualify for additional medical management.

Myriad has an exclusive partnership with SRL Inc. to commercialize the BRACAnalysis Diagnostic System in Japan.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Royal Philips has recalled specific sleep and respiratory care devices due to the potential health risks related to the polyester-based polyurethane or PE-PUR sound abatement foam component. The affected products include Bi-Level Positive Airway Pressure or Bi-Level PAP, Continuous Positive Airway Pressure or CPAP, and mechanical ventilator devices. Freshpet Inc. is recalling a single lot of Freshpet Select Small Dog Bite Size Beef & Egg Recipe Dog Food citing the potential contamination with Salmonella, a bacterium, the U.S. Food and Drug Administration said. The product comes in 1 LB bags, with UPC code of 627975012939, lot code of 1421FBP0101 and sell by date of 10/30/2021. Google has revoked its three-year ban on cryptocurrency-related ads on its sites under the search giants' new ad services policy. This action will now allow cryptocurrency exchanges and wallets certified by Google to advertise their products and services on Google's network, beginning August 3, 2021.
Follow RTT